Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 52, Issue 1, 2007, Pages 18-24

  Ruhl, A P ^a   Ganz, J E ^a   Bickston, S J ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Extraintestinal manifestations; Inflammatory bowel disease; Neutrophilic folliculitis; Pyoderma gangrenosum; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; COLON EPITHELIUM PROTEIN; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; INFLIXIMAB; MESALAZINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; PROTEIN; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; TROPOMYOSIN; UNCLASSIFIED DRUG;

APPENDECTOMY; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ENTERITIS; FOLLICULITIS; HUMAN; IMMUNOPATHOGENESIS; NEUTROPHILIC FOLLICULITIS; PATHOGENESIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN BIOPSY; SKIN DEFECT; SMOKING; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

DIAGNOSIS, DIFFERENTIAL; FOLLICULITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; NEUTROPHILS; PYODERMA GANGRENOSUM; SKIN; ULCER;

EID: 33846313674     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9361-4     Document Type: Review

References (53)

1. Powell FC, Ahmadi S (2005) Pyoderma gangrenosum: uncommon presentations. Clin Dermatol 23:612-620
2. Weenig RH, Davis MDP, Dahl PR, Daniel Su WP (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Medicine 347:1412-1418
3. Kuner N, Hartschuh W (2000) Darstellung des Pyoderma gangraenosum in einem dermatologishcen Atlas des fruehern 19, Jahrhunderts. Hautarzt 51:519-523
4. Devergie MN (1826) Clinique de la Maladie Syphilitique, Atlas colorie. FM Maurice, Libraire editeur, Paris
5. Brunstig LA, Goeckerman WH, O'Leary PA (1930) Pyoderma (ecthyma) gangrenosum. Clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 22:655-680
6. Vignon-Pennamen MD, Wallach D (1991) Cutaneous manifestations of neutrophilic disease: a study of seven cases. Dermatogica 183:255-264
7. Van den Driesch P (1997) Pyoderma gangrenosum:a report of 44 cases with f follow-up. Br J Dermatol 137:1000-1005
8. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB, White WL, Callen JP (2000) Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79:37-46
9. Perry HO, Brunstig LA (1957) Pyoderma gangrenosum. A clinical study of nineteen cases. Am Med Assoc Arch Dermatol 75:380-386
10. Prystowsky JH, Khan SN, Lazarus GS (1989) Present status of pyoderma gangrenosum: review of 21 cases. Arch Dermatol 125:57-64
11. Mir-Madjlessi SH, Taylor JS, Farmer RG (1985) Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 80:615-620
12. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RKS (1991) Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 78:676-678
13. Sapienza MS, Cohen S, Dimarino AJ (2004) Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci 49:1454-1457
14. Mimouni D, Anhalt GJ, Kouba DJ, Nousari HC (2003) Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol 148:813-816
15. Su CG, Judge TA, Lichtenstein GR (2002) Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 31:307-327
16. Das KM (1999) Relationship of extraintestinal involvements in inflammatory bowel disease; new insights into autoimmune pathogenesis. Dig Dis Sci 44:1-13
17. Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, GArgano D, Somma P, Mansueto G, Peluso R, Scarpa R, D'Armiento FP, Astarita C, Ayala F, Renda A, Mazzacca G, D'Arienzo A (2004) cigarrette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 99:327-334
18. Powell FC, Su D, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34(3):395-409
19. Powell FC, Collins S (2000) Pyoderma gangrenosum. Clin Dermatol 18:283-293
20. Papageogiou KI, Mathew RG, Kaniorou-Larai MG, Yiakoumetis A (2005) Pyoderma gangrenosum in ulcerative colitis:considerations for an early diagnosis. Br Med J 331:1323-1324
21. Byrne JPH, Hewitt M, Summerly R (1976) Pyoderma gangrenosum associated with chronic active hepatitis:report of two cases. Arch Dermatol 112:1297-1230
22. Powell FC, Schroeter AL, Daniel Su WP (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55:173-186
23. Thornton JR, Teague RJ, Low-Bier TS, et al. (1980) Pyoderma gangrenousm in ulcerative colitis. Gut 21:247-248
24. Das KM, Dubin R, Nagai T (1978) Isolation and characterization of colonic tissue bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci USA 75:4528-4532
25. Geng X, Baincone L, Dai HH, Lin J, Yoshizaki N, Dasgupta A, Pallone F, Das KM (1998) Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology 114:912-922
26. O'Loughlin S, Perry HO (1978) A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 114:1061-1064
27. Basler MD, Dubin HV (1976) Ulcerative colitis and the skin. Arch Dermatol 112:531-534
28. Fenske NA, Gern JE, Pierce D, Vasey FB (1983) Vesiculopapular eruption of ulcerative colitis. Arch Dermatol 119:664-669
29. Callen JP, Woo TY (1985) Vesiculopapular eruption of ulcerative colitis. Arch Dermatol 121:339-344
30. Callen JP (1998) Pyoderma gangrenosum. Lancet 351:581-585
31. Finkel SI, Janowitz HD (1981) Trauma and pyoderma gangrenosum of inflammatory bowel disease. Gut 22:410-412
32. Moschella SL (2005) Neutrophilic dermatoses. Available at: uptodate.com
33. Barnes L, Lucky AW, Bucuvalas JC, Suchy FJ (1986) Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. J Am Acad Dermatol 15:608-614
34. Dicken CH (1986) Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass. J Am Acad Dermatol 14:792-796
35. Delaney TA, Clay CD, Randell PL (1989) The bowel-associated dermatosis- arthritis syndrome. Australas J Dermatol 30:23-27
36. Van Hale H, Rogers RS, Zone JJ (1985) Pyostomatitis vegetans: a reactive mucosal marker for inflammatory disease of the gut. Arch Dermatol 121:67-77
37. Basler RS (1980) Ulcerative colitis and the skin. Med Clin North Am 64:941-954
38. Hughes AP, Jackson JM, Callen JP (2000) Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284:1546-1548
39. Blitz NM, Rudikoff D (2001) Pyoderma gangrenosum. Mt Sinai J Med 68:287-297
40. Brooklyn TN, Dunnill GS, Shetty A, Bowden JJ, Williams JDL, Griffiths CEM, Forbes AEM, Greenwood R, Probert CS (2005) Infliximab for the treatment of pyoderma gangrenosum: a randomized, double-blind placebo-controlled trial. Gut doi:10.1136/gut.2005.074815
41. Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53:273-283
42. Chow RKP, Ho VC (1996) Treatment of pyoderma gangrenosum. J Am Acad Dermatol 34:1047-1060
43. Reich K, Vente C, Neumann C (1998) Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol 139:755-757
44. Chiba T, Isomura I, Suzuki A, Morita A (2005) Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 32:199-203
45. Powell RJ, Holbrook MR, Stevens A (1997) Pyoderma gangrenosum and its treatment. Lancet 350:1720-1721
46. Matis WL, Ellis CN, Griffiths CEM, Lazarus GS (1992) Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 128:1060-1064
47. Hong JJ, Merel NH, Hanauer SB (2001) Treatment of pyoderma gangrenosum complicating Crohn's disease with infliximab. Gastroenterology 120:A621
48. Brooklyn TN et al. (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55:505-509
49. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429
50. Trost LB, McDonnell JK (2005) Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 81:580-585
51. Powell FC, Perry HO (1984) Pyoderma gangrenosum in childhood. Arch Dermatol 120:757-761
52. Cox NH, Peebles-Brown DA, Mackie RM (1986) Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. Br J Hosp Med 36:363
53. Su DWP, Davis MDP, Weenig RH, Powell FC, Perry HO (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Into J Dermatol 43:790-800